摘要
AbstractBiologic drugs have been increasingly used in the treatment of psoriasis and are especially favorable for severe, recalcitrant, and special-type cases. Therefore, appropriate, effective, and safe use of biologic drugs has drawn attention from dermatologists. For this purpose, Chinese experts majoring in psoriasis analyzed domestic and international research data, summarized current clinical experiences, investigated features of Chinese patients with psoriasis, and finally formulated the present consensus, which provides detailed guidances to clinicians in terms of the principles and methods of the application of biologics, the efficacy and safety profile, patient screening and monitoring, main adverse events and corresponding solutions, and precautions for special patient populations.
机构地区
,Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China,Department of Dermatology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China,Hospital for Skin Diseases (Institute of Dermatology), Chinese Academy of Medical Sciences, Nanjing, Jiangsu 210042, China,Department of Dermatology, Changhai Hospital, The Second Military Medical University, Shanghai 200002, China,Department of Dermatology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing 401120, China,Department of Dermatology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China,Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China,Department of Dermatology, People’s Hospital of Xinjiang Uygur Autonom
出版日期
2020年08月12日（中国期刊网平台首次上网日期，不代表论文的发表时间）
